Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 93210

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
September 28, 2023
Product types
Food
Classifications
Class III
Statuses
Terminated
Recalling firm wording
ActiPharma, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Food Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

food · product 1 of 1

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.

F-0463-2024
Recall number
F-0463-2024
Initiated
September 28, 2023
Classification
Class III
Status
Terminated
Recalling firm
ActiPharma, Inc.
Quantity
607 bottles of 100 tablets each

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.

Code information

Lot 13309, Exp: 01/26

Distribution pattern

Domestic distribution, in Puerto Rico.